Biote Corp (NAS:BTMD)

Q2 2026 Biote Corp Earnings Call Transcript

Aug 5, 2026 / 09:00 PM GMT

Release Date Price: $2.26 (-0.44%)

Transcript 10-Q8-K

Key Points

Positve

Biote Corp (BTMD) has successfully resolved the voluntary product recall and Asteria Health is now operating at normalized inventory and increased production levels with a second production shift.
The company expects improved profitability in the second half of 2026 as it increases the supply of internally manufactured pellets, reducing reliance on higher-cost third-party suppliers.
Dietary supplements revenue grew 5.7% in Q2 2026, driven by continued growth in the e-commerce channel, and is forecasted to grow at a mid to high single-digit rate for the full year.
Management has strengthened the corporate culture, realigned the commercial team, and is implementing a data-driven, performance-oriented approach to drive sustainable growth.
Biote Corp (BTMD) is actively evaluating inorganic growth opportunities to expand its platform and accelerate strategic progress, complementing its organic growth initiatives.
The company has resolved many outstanding legal matters, which is expected to reduce quarterly legal expenses going forward.

Negative

Biote Corp (BTMD) reported a 9.5% decrease in total revenue to $44.2 million in Q2 2026, with procedure revenue declining 13.9% to $30.3 million.
The voluntary product recall negatively impacted Q2 results, with an estimated $3.3 million impact on procedure revenue and $0.6 million in incremental costs, leading to a gross margin decline to 65.4% from 71.6%.
The company experienced elevated clinic attrition (around 8%) and slower productivity from new clinics, as the sales team was focused on supporting recall-impacted clinics.
Biote Corp (BTMD) revised its full-year 2026 guidance downward, now expecting revenue above $175 million and adjusted EBITDA above $25 million, compared to prior guidance of revenue above $190 million and adjusted EBITDA above $38 million.
The company reported a net loss of $7.4 million and diluted loss per share of $0.23 in Q2 2026, compared to net income of $3.9 million and EPS of $0.10 in the prior year period.
SG&A expenses increased significantly to $32.4 million from $24.2 million, driven by higher legal expenses, and cash flow used by operations was negative $1.2 million in the quarter.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BTMD.OQ - biote Corp
Q2 2026 Biote Corp Earnings Call
Aug 05, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. My name is Tina and I will be your conference operator.

At this time, I would like to welcome everyone to the IoT Second Quarter 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question-and-answer session. To ask a question, press star 1 on your telephone keypad. To withdraw your question, press star 1 again.

It is now my pleasure to turn the call over to Simon Cerevitski, Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.